| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥29.89B | -17.1% |
| Gross profit | ¥1.55B | — |
| Operating income | ¥-0.95B | — |
| Net income | ¥-1.22B | -126.5% |
| Gross margin | 5.2% | Net margin -4.1% |
| Revenue Q/Q | -7.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥28.35B | 94.8% |
| R&D | ¥0.38B | 1.3% |
| SG&A | ¥1.29B | 4.3% |
| Tax & other | ¥0.27B | 0.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
国信证券 ・ 英维克 ・ 深南电路 ・ 德赛西威 ・ 鹏鼎控股 ・ 中国广核 ・ 亿纬锂能 ・ 爱尔眼科 ・ 同花顺 ・ 东方财富 ・ 智飞生物 ・ 汇川技术
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies